Erscheint: Dezember 2026
Buch (Softcover): Fachbuch
The Microbiome and Cancer Treatment
Overcoming Resistance and Enhancing Efficacy
Verlag:
Elsevier Unsere-Artikel-Nr.: P35952626
EAN: 9780443332067
Erscheint: Dezember 2026
Versand: Kostenlos
-22.4 %
CHF 255.–
CHF 198.–
Beschreibung
The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy. delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance. Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.
Spezifikationen
Sprache
- Englisch
Autor
- Singh Arun Kumar
- Meenakshi Dhanawat
- Malik Garima
- Sadhna Aggarwal
Erscheinungsjahr
- 2026
Format
- Buch (Softcover)